TrialCancer science2012

First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.

Yasushi Tsuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.